Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-006044

SVP & Chief Operating Officer sold 63,000 shares at $42.82 ($2,697,660)

  • SVP & Chief Operating Officer acquired 63,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nicholson John SVP & Chief Operating Officer 2019-01-28 Option exercise +63,000 $10.69 $673,470 237,477 D
Nicholson John SVP & Chief Operating Officer 2019-01-28 Sale −63,000 $42.82 $2,697,660 174,477 D
Derivatives
Nicholson John SVP & Chief Operating Officer 2019-01-28 Option exercise · Stock Option −63,000 $10.69 $673,470 0 D
Open-market sales · 63,000 sh · avg $42.82 · $2,697,660
Loading xslF345X03/doc4.xml…